Royal Bank of Canada’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-153
Closed 7223
2024
Q1
$0 Sell
153
-147
-49% ﹤0.01% 7138
2023
Q4
$0 Sell
300
-362
-55% ﹤0.01% 7117
2023
Q3
$0 Buy
662
+379
+134% ﹤0.01% 7164
2023
Q2
$1K Buy
+283
New +$1K ﹤0.01% 6684
2023
Q1
Sell
-2
Closed 7056
2022
Q4
$0 Sell
2
-27
-93% ﹤0.01% 7318
2022
Q3
$0 Sell
29
-2,396
-99% ﹤0.01% 7436
2022
Q2
$51K Sell
2,425
-3,299
-58% -$69.4K ﹤0.01% 5249
2022
Q1
$215K Buy
5,724
+2,240
+64% +$84.1K ﹤0.01% 4550
2021
Q4
$196K Buy
3,484
+1,855
+114% +$104K ﹤0.01% 4836
2021
Q3
$117K Sell
1,629
-2,669
-62% -$192K ﹤0.01% 5089
2021
Q2
$412K Buy
4,298
+3,736
+665% +$358K ﹤0.01% 4007
2021
Q1
$83K Buy
562
+308
+121% +$45.5K ﹤0.01% 5097
2020
Q4
$36K Buy
254
+164
+182% +$23.2K ﹤0.01% 5250
2020
Q3
$14K Hold
90
﹤0.01% 5337
2020
Q2
$16K Buy
+90
New +$16K ﹤0.01% 5202
2019
Q2
Sell
-1
Closed 6075
2019
Q1
$0 Hold
1
﹤0.01% 5991
2018
Q4
$0 Hold
1
﹤0.01% 6209
2018
Q3
$0 Hold
1
﹤0.01% 6312
2018
Q2
$0 Hold
1
﹤0.01% 6124
2018
Q1
$0 Buy
+1
New ﹤0.01% 6061
2017
Q4
Hold
0
6111
2017
Q3
Hold
0
6177
2017
Q2
Hold
0
5993
2017
Q1
Hold
0
6022
2016
Q4
Sell
-3
Closed -$3K 5969
2016
Q3
$3K Sell
3
-45
-94% -$45K ﹤0.01% 5344
2016
Q2
$52K Buy
48
+43
+860% +$46.6K ﹤0.01% 4412
2016
Q1
$6K Hold
5
﹤0.01% 5175
2015
Q4
$12K Sell
5
-8
-62% -$19.2K ﹤0.01% 5153
2015
Q3
$14K Sell
13
-4
-24% -$4.31K ﹤0.01% 5136
2015
Q2
$17K Hold
17
﹤0.01% 5290
2015
Q1
$17K Buy
+17
New +$17K ﹤0.01% 4958
2014
Q3
Sell
-3
Closed -$10K 5539
2014
Q2
$10K Buy
+3
New +$10K ﹤0.01% 4905